The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application

Jasper E Palmier-Claus, John Ainsworth, Matthew Machin, Cristine Barrowclough, Graham Dunn, Emma Barkus, Anne Rogers, Til Wykes, Shitij Kapur, Iain Buchan, Emma Salter, Shôn W Lewis, Jasper E Palmier-Claus, John Ainsworth, Matthew Machin, Cristine Barrowclough, Graham Dunn, Emma Barkus, Anne Rogers, Til Wykes, Shitij Kapur, Iain Buchan, Emma Salter, Shôn W Lewis

Abstract

Background: Semi-structured interview scales for psychosis are the gold standard approach to assessing psychotic and other symptoms. However, such assessments have limitations such as recall bias, averaging, insensitivity to change and variable interrater reliability. Ambulant, real-time self-report assessment devices may hold advantages over interview measures, but it needs to be shown that the data thus collected are valid, and the collection method is acceptable, feasible and safe. We report on a monitoring system for the assessment of psychosis using smartphone technology. The primary aims were to: i) assess validity through correlations of item responses with those on widely accepted interview assessments of psychosis, and ii) examine compliance to the procedure in individuals with psychosis of varying severity.

Methods: A total of 44 participants (acute or remitted DSM-4 schizophrenia and related disorders, and prodromal) completed 14 branching self-report items concerning key psychotic symptoms on a touch-screen mobile phone when prompted by an alarm at six pseudo-random times, each day, for one week. Face to face PANSS and CDS interviews were conducted before and after the assessment period blind to the ambulant data.

Results: Compliance as defined by completion of at least 33% of all possible data-points over seven days was 82%. In the 36 compliant participants, 5 items (delusions, hallucinations, suspiciousness, anxiety, hopelessness) showed moderate to strong (rho 0.6-0.8) associations with corresponding items from interview rating scales. Four items showed no significant correlation with rating scales: each was an item based on observable behaviour. Ambulant ratings showed excellent test-retest reliability and sensitivity to change.

Conclusions: Ambulatory monitoring of symptoms several times daily using smartphone software applications represents a feasible and valid way of assessing psychotic phenomena for research and clinical management purposes. Further evaluation required over longer assessment periods, in clinical trials and service settings.

Figures

Figure 1
Figure 1
A screenshot of the question response page.
Figure 2
Figure 2
A screenshot of the researcher administration page.

References

    1. Lewis SW, Buchanan R. Schizophrenia . 3. Oxford: Healthpress; 2007.
    1. Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ. 2007;10:23.
    1. Kay SR, Flszbein A, Opfer LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261.
    1. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3:247–251. doi: 10.1016/0920-9964(90)90005-R.
    1. Perkins DO, Wyatt RJ, Bartko JJ. Penny-wise and pound-foolish: the impact of measurement error on sample size requirements in clinical trials. Biol Psychiatry. 2000;47:762–766. doi: 10.1016/S0006-3223(00)00837-4.
    1. Müller MJ, Szegedi A. Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials. J Clin Psychopharmacol. 2002;22:318. doi: 10.1097/00004714-200206000-00013.
    1. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Res. 2004;72:29–39. doi: 10.1016/j.schres.2004.09.007.
    1. Drake RJ, Pickles A, Bentall RP, Kinderman P, Haddock G, Tarrier N, Lewis SW. The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med. 2004;34:285–292. doi: 10.1017/S0033291703008821.
    1. Lincoln TM, Ziegler M, Lüllmann E, Müller MJ, Rief W. Can delusions be self-assessed? Concordance between self-and observer-rated delusions in schizophrenia. Psychiatry Res. 2010;178:249–254. doi: 10.1016/j.psychres.2009.04.019.
    1. Hamera EK, Kraenzle Schneider J, Potocky M, Casebeer MA. Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders. Schizophr Res. 1996;19:213–219. doi: 10.1016/0920-9964(95)00100-X.
    1. Liraud F, Droulout T, Parrot M, Verdoux H. Agreement between self-rated and clinically assessed symptoms in subjects with psychosis. J Nerv Ment Dis. 2004;192:352. doi: 10.1097/01.nmd.000126702.30745.1d.
    1. Ben-Zeev D, Morris S, Swendsen J, Granholm E. Predicting the Occurrence, Conviction, Distress, and Disruption of Different Delusional Experiences in the Daily Life of People with Schizophrenia. Schizophr Bull. 2011;37(6):1248–1256. doi: 10.1093/schbul/sbq041.
    1. Granholm E, Loh C, Swendsen J. Feasibility and validity of computerized ecological momentary assessment in schizophrenia. Schizophr Bull. 2008;34:507–514.
    1. Ben-Zeev D, Ellington K, Swendsen J, Granholm E. Examining a cognitive model of persecutory ideation in the daily life of people with schizophrenia: a computerized experience sampling study. Schizophr Bull. 2011;37:1248–1256. doi: 10.1093/schbul/sbq041.
    1. Swendsen J, Ben-Zeev D, Granholm E. Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia. Am J Psychiatry. 2011;168:202–209. doi: 10.1176/appi.ajp.2010.10030463.
    1. The Communications Market . 2011. (August) [ ]
    1. Yung AR, McGorry PD, McFarlane CA, Patton GC. The PACE Clinic: development of a clinical service for young people at high risk of psychosis. Australas Psychiatry. 1995;3:345–349. doi: 10.3109/10398569509085280.
    1. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C. Mapping the onset of psychosis: the Comprehensive Assessment of At Risk Mental States. Aust N Z J Psychiatry. 2005;39:964–971. doi: 10.1080/j.1440-1614.2005.01714.x.
    1. Myin-Germeys I, van Os J, Schwartz JE, Stone AA, Delespaul PA. Emotional reactivity to daily life stress in psychosis. Arch Gen Psychiatry. 2001;58:1137. doi: 10.1001/archpsyc.58.12.1137.
    1. Addington D, Addington J, Maticka-Tyndale E, Joyce J. Reliability and validity of a depression rating scale for schizophrenics. Schizophr Res. 1992;6:201–208. doi: 10.1016/0920-9964(92)90003-N.
    1. Palmier-Claus S, Myin-Germeys I, Barkus E, Bentley L, Udachina A, Delespaul P, Lewis S, Dunn G. Experience sampling research in individuals with mental illness: reflections and guidance. Acta Psychiatr Scand. 201;123:12–20.
    1. Appelbaum PS, Robbins PC, Roth LH. Dimensional approach to delusions: comparison across types and diagnoses. Am J Psychiatry. 1999;156:1938–1943.
    1. Delespaul P. Assessing schizophrenia in daily life: The experience sampling method (pp. 65-67) Maastricht, the Netherlands: Universitaire Pers Maastricht; 1995.
    1. StataCorporation. Stata reference manual, release 10.0 . Stata Press: College Station, TX; 2007.
    1. SPSSInc. SPSS 15.0 for Windows . Chicago: SPSS Inc; 2006.
    1. Ebner-Priemer UW, Kuo J, Kleindienst N, Welch SS, Reisch T, Reinhard I, Lieb K, Linehan MM, Bohus M. State affective instability in borderline personality disorder assessed by ambulatory monitoring. Psychol Med. 2007;37:961–970. doi: 10.1017/S0033291706009706.
    1. Palmier-Claus J, Taylor P, Gooding P, Dunn G, Lewis S. Affective variability predicts suicidal ideation in individuals at ultra‐high risk of developing psychosis: An experience sampling study. Br J Clin Psychol. 2012;51:72–83. doi: 10.1111/j.2044-8260.2011.02013.x.
    1. Wichers M, Simons CJP, Kramer IMA, Hartmann JA, Lothmann C, Myin-Germeys I, van Bemmel AL, Peeters F, Delespaul P, van Os J. Momentary assessment technology as a tool to help patients with depression help themselves. Acta Psychiatr Scand. 2011;124:262–272. doi: 10.1111/j.1600-0447.2011.01749.x.
    1. Myin-Germeys I, Birchwood M, Kwapil T. From Environment to Therapy in Psychosis: A Real-World Momentary Assessment Approach. Schizophr Bull. 2011;37:244. doi: 10.1093/schbul/sbq164.
    1. Palmier Claus J. The clinical uses of momentary assessment. Acta Psychiatr Scand. 2011;124:241–242. doi: 10.1111/j.1600-0447.2011.01761.x.
    1. Agid O, Kapur S, Arenovich T, Zipursky RB. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry. 2003;60:1228. doi: 10.1001/archpsyc.60.12.1228.
    1. Kapur S, Arenovich T, Agid O, Zipursky R, Lindborg S, Jones B. Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry. 2005;162:939–946. doi: 10.1176/appi.ajp.162.5.939.
    1. Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010;15:1–39. doi: 10.1348/135910709X466063.
    1. Kelly J, Gooding P, Pratt D, Ainsworth J, Welford M, Tarrier N. Intelligent Real Time Therapy (iRTT): Harnessing the power of machine learning to optimise the delivery of momentary cognitive-behavioural interventions. J Ment Health. pp. 404–414.
    1. Granholm E, Ben-Zeev D, Link PC, Bradshaw KR, Holden JL. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations. Schizophr Bull. 2012;38(3):414–425. doi: 10.1093/schbul/sbr155.
    1. Rogers A, Kirk S, Gately C, Mat CR, Finch T. Established users and the making of telecare work in long term condition management: implications for health policy. Soc Sci Med. 2011;72:1077–1184. doi: 10.1016/j.socscimed.2011.01.031.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever